Review article · 2026 · Open access
Next-generation T cell engagers for cancer and autoimmune diseases
Frontiers in Immunology, 17, 1885909 · Published 22 July 2026 · DOI 10.3389/fimmu.2026.1885909
In brief
“Next-generation T cell engagers for cancer and autoimmune diseases” is a 2026 review article by Jennifer S. Michaelson and 3 co-authors, published in Frontiers in Immunology. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.
- Citations
- 0
- References
- 148
- Authors
- 4
Abstract
T cell-engaging antibody constructs (TCEs) have emerged as a potent modality to treat cancer and autoimmune diseases. Twelve TCEs have been approved by the FDA and EMA for the treatment of hematological malignancies or solid tumors. Despite the varying designs and binding properties, they all lead to robust single-agent efficacy and approvals in refractory or relapsed leukemia, lymphomas, multiple myeloma (MM), small cell lung cancer, EpCAM-expressing cancers or uveal melanoma. Where comparisons can be deduced, TCEs appear to achieve response rates like those obtained with CAR-T cell therapies. Given the success of the first generation of TCEs, considerable attempts are underway to further improve upon this modality. With the goal of expanding TCEs into other malignant and autoimmune indications, and to further enhance efficacy and improve safety, a multitude of novel TCEs are currently in preclinical and clinical development. Here we review the current approaches to developing next-generation TCEs that can widen the therapeutic index, address heterogeneous target expression, and thereby potentially improve efficacy and safety.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Michaelson, J. S., Henry, C. C., Sauer, K., & Baeuerle, P. A. (2026). Next-generation T cell engagers for cancer and autoimmune diseases. Frontiers in Immunology, 17, 1885909. https://doi.org/10.3389/fimmu.2026.1885909
MLA 9
Michaelson, Jennifer S., et al. “Next-generation T cell engagers for cancer and autoimmune diseases.” Frontiers in Immunology, vol. 17, 2026, p. 1885909. https://doi.org/10.3389/fimmu.2026.1885909.
Chicago
Michaelson, Jennifer S., Catherine C. Henry, Karsten Sauer, and Patrick A. Baeuerle. 2026. “Next-generation T cell engagers for cancer and autoimmune diseases.” Frontiers in Immunology 17: 1885909. https://doi.org/10.3389/fimmu.2026.1885909.
Harvard
Michaelson, J. S. et al. (2026) ‘Next-generation T cell engagers for cancer and autoimmune diseases’, Frontiers in Immunology, 17, p. 1885909. doi:10.3389/fimmu.2026.1885909.
IEEE
J. S. Michaelson, C. C. Henry, K. Sauer, and P. A. Baeuerle, “Next-generation T cell engagers for cancer and autoimmune diseases,” Frontiers in Immunology, vol. 17, p. 1885909, 2026, doi: 10.3389/fimmu.2026.1885909.
BibTeX
@article{michaelson2026next,
title = {{Next-generation T cell engagers for cancer and autoimmune diseases}},
author = {Michaelson, Jennifer S. and Henry, Catherine C. and Sauer, Karsten and Baeuerle, Patrick A.},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
pages = {1885909},
doi = {10.3389/fimmu.2026.1885909},
url = {https://doi.org/10.3389/fimmu.2026.1885909}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- T cell-engaging antibody
- bispecific antibodies
- cancer immunotherapy
- autoimmune disease
- hematologic malignancies
- multiple myeloma
- small cell lung cancer
- uveal melanoma
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Michaelson, J. S., Henry, C. C., Sauer, K., & Baeuerle, P. A. (2026). Next-generation T cell engagers for cancer and autoimmune diseases. Frontiers in Immunology, 17, 1885909. https://doi.org/10.3389/fimmu.2026.1885909
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.
Who wrote this paper?
Jennifer S. Michaelson, Catherine C. Henry, Karsten Sauer, Patrick A. Baeuerle.
What is the DOI of this paper?
10.3389/fimmu.2026.1885909, permanently at https://doi.org/10.3389/fimmu.2026.1885909. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.